Sriram S. Shanmugavelandy
The University of Texas MD Anderson Cancer Center(US)AbbVie (United States)(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Sphingolipid Metabolism and Signaling, Acute Myeloid Leukemia Research, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Encapsulation of Organic Molecules in Calcium Phosphate Nanocomposite Particles for Intracellular Imaging and Drug Delivery(2008)291 cited
- → Targeted Indocyanine-Green-Loaded Calcium Phosphosilicate Nanoparticles for In Vivo Photodynamic Therapy of Leukemia(2011)176 cited
- → Bioconjugation of Calcium Phosphosilicate Composite Nanoparticles for Selective Targeting of Human Breast and Pancreatic Cancers In Vivo(2010)133 cited
- → Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models(2013)89 cited
- → Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia(2010)86 cited
- → Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer(2017)68 cited